The European Interbalkan Medical Center, is a major private general hospital located and based in Thessaloniki, Greece, on the road to the airport, opposite of the commercial center of Apollonia and close to Mediterranean Cosmos. It was founded by businessman Giorgos Apostolopoulos in 2000.

There are 383 beds in Interbalkan Medical Center of Thessaloniki.

During the past decade, Interbalkan Medical Center of Thessaloniki conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 6 clinical trials were completed, i.e. on average, 20.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 6 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Interbalkan Medical Center of Thessaloniki" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Loxo Oncology, Inc." with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Interbalkan Medical Center of Thessaloniki" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Everest Medicines" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Interbalkan Medical Center of Thessaloniki" are "Breast Neoplasms" (3 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Atrial Fibrillation" (2 trials), "Functional Mitral Regurgitation" (2 trials) and "Melanoma" (2 trials). Many other conditions were trialed in "Interbalkan Medical Center of Thessaloniki" in a lesser frequency.

Most popular intervention types in "Interbalkan Medical Center of Thessaloniki" are "Drug" (21 trials), "Biological" (6 trials), "Device" (6 trials), "Other" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Docetaxel" (3 trials), "Pembrolizumab" (3 trials), "Selpercatinib" (3 trials) and "Abemaciclib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Interbalkan Medical Center of Thessaloniki" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Interbalkan Medical Center of Thessaloniki". undefined are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Interbalkan Medical Center of Thessaloniki, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Interbalkan Medical Center of Thessaloniki, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".